Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inhibitors of ras-transformed cell growth under study at Yuhan

May 6, 1999

Select Therapeutics submits IND in Canada

May 6, 1999

Bio-Technology announces two oncology collaborations

May 6, 1999

Telomerase inhibitor identified during screening of microbial metabolites

May 5, 1999

Novel tricyclic inhibitors of protein farnesyltransferase claimed by Schering-Plough

May 5, 1999

Georgetown U. discloses new series with the ability to activate PKC

May 5, 1999

Licensing opportunity from NIH: oligonucleotides for enhancing the activity of antitumor drugs

May 5, 1999

FDA approves UroCor's prostate cancer radiation implants

May 4, 1999

Incyte discovers novel human tumor suppressor with application in cancer, autoimmune diseases

May 4, 1999

BMS files for approval of new indication for paclitaxel

May 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...